Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 0.3714M
June 30, 2026 0.5628M
March 31, 2026 0.847M
December 31, 2025 1.647M
September 30, 2025 2.396M
June 30, 2025 2.542M
March 31, 2025 3.362M
December 31, 2024 3.942M
September 30, 2024 4.050M
June 30, 2024 4.810M
March 31, 2024 4.433M
December 31, 2023 3.320M
September 30, 2023 2.566M
June 30, 2023 1.943M
March 31, 2023 1.267M
December 31, 2022 1.589M
September 30, 2022 1.478M
June 30, 2022 1.234M
March 31, 2022 1.214M
December 31, 2021 1.137M
September 30, 2021 1.032M
June 30, 2021 1.315M
March 31, 2021 1.226M
December 31, 2020 0.6998M
September 30, 2020 1.174M
Date Value
June 30, 2020 0.6652M
March 31, 2020 0.7385M
December 31, 2019 0.8079M
September 30, 2019 0.4857M
June 30, 2019 0.6176M
March 31, 2019 0.8262M
December 31, 2018 0.8812M
September 30, 2018 0.9952M
June 30, 2018 0.9827M
March 31, 2018 0.7691M
December 31, 2017 0.7175M
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
June 30, 2015
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2011 0.00
June 30, 2011 0.00
March 31, 2011 0.00
December 31, 2010 0.00

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Oncolytics Biotech, Inc. 13.18M
Sangamo Therapeutics, Inc. 113.79M
Sarepta Therapeutics, Inc. 647.26M
Anixa Biosciences, Inc. 4.828M
Vicapsys Life Sciences, Inc. 0.0043M